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A surface-enhanced Raman spectroscopy (SERS) method combined with multivariate analysis was developed for non-invasive 
gastric cancer detection. SERS measurements were performed on two groups of blood plasma samples: one group from 32 
gastric patients and the other group from 33 healthy volunteers. Tentative assignments of the Raman bands in the measured 
SERS spectra suggest interesting cancer-specific biomolecular changes, including an increase in the relative amounts of nucle-
ic acid, collagen, phospholipids and phenylalanine and a decrease in the percentage of amino acids and saccharide in the blood 
plasma of gastric cancer patients as compared with those of healthy subjects. Principal components analysis (PCA) and linear 
discriminant analysis (LDA) were employed to develop effective diagnostic algorithms for classification of SERS spectra be-
tween normal and cancer plasma with high sensitivity (79.5%) and specificity (91%). A receiver operating characteristic (ROC) 
curve was employed to assess the accuracy of diagnostic algorithms based on PCA-LDA. The results from this exploratory 
study demonstrate that SERS plasma analysis combined with PCA-LDA has tremendous potential for the non-invasive detec-
tion of gastric cancers. 
surface-enhanced Raman spectroscopy (SERS), blood plasma, gastric cancer, detection 
 
Citation:  Feng S Y, Pan J J, Wu Y A, et al. Study on gastric cancer blood plasma based on surface-enhanced Raman spectroscopy combined with multivariate 




Raman spectroscopy (RS) can provide fingerprint type in-
formation on the structure and conformation of specific 
molecular species [1]. It has been used for molecule detec-
tion and material identification. RS has also been widely 
applied for biomedical research [2–8]. Changes in the con-
formation and components of human tissues and cells can 
be explored by detecting species such as DNA, protein, and 
lipid. This technique has attracted considerable attention 
due to its great potential for cancer diagnosis. For example, 
several researchers have studied the blood serum and cells 
obtained from gastric cancer patients and healthy volunteers 
by Raman spectra under a 523 nm green laser, which was 
considered effective for gastric cancer screening, prognosis 
monitoring and efficacy evaluation [9–11]. Tao et al. [12] 
applied RS to analyze the apoptosis of human gastric cancer 
cells induced by cisplatin and demonstrated that cisplatin 
could induce the apoptosis of gastric cancer cells by de-
creasing the nucleic acid and protein content. Zhang et al. 
[13], Ling et al. [14] and Tang et al. [15] also used RS to 
study in vitro tissues and showed a number of differences 
between normal and gastric cancer tissue, indicating that RS 
would become an effective assistant method for gastric 
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cancer diagnosis. 
All studies mentioned above used conventional Raman 
spectroscopy for gastric cancer detection. However, Raman 
scattering suffers the disadvantage of extremely poor effi-
ciency, especially for biological molecules, because of its 
inherently small cross-section [16]. This inefficient scatter-
ing requires the use of high laser power and/or long data 
collection times for spectral acquisition that could damage 
biological samples. Meanwhile, the Raman spectra of bio-
logical samples are often superimposed on a strongly fluo-
rescent background that may be overwhelming and make it 
difficult to analyze the Raman signals. 
Surface-enhanced Raman scattering (SERS) was first 
reported in 1974 by Fleischman et al. [17], who observed 
the surface-enhanced Raman spectrum of pyridine adsorbed 
on electrochemically roughened silver electrodes. With the 
SERS technique, Raman signals can be enhanced dramati-
cally, with low laser power and little damage to biological 
molecules when the probed molecules are attached to 
nano-textured metallic surfaces, while the autofluorescent 
background can be greatly reduced at the same time. In ad-
dition, the SERS technology has a high detection sensitivity 
and is capable of realizing single molecule detection. 
Therefore, it is particularly suitable for research into bio-
logical molecules [18]. 
Recently, the SERS technique has been widely used in 
biomedical applications, including detection of various bio-
logical agents (viruses, bacteria, and DNA) [19–21]. Cancer 
diagnosis is another potential application for the SERS 
technique. Most current oncology applications are focused 
on developing a SERS-based immunoassay, which relies on 
a specific interaction between an antigen and a complemen-
tary antibody [22–29]. 
Gastric cancer is one of the most common malignancies 
and has the highest incidence among all malignancies in 
China. Eastern Asia, South American and Eastern Europe 
have very high incidences of stomach cancers, accounting 
for 600000 deaths worldwide every year. Human blood 
plays an important role in our body, can be sampled con-
veniently and is closely related to the state of human health. 
Therefore, changes of blood may be associated with the 
occurrence of some diseases.  
Our group has recently applied SERS to blood plasma 
analysis for nasopharyngeal cancer detection and obtained 
good preliminary results [30]. In this paper, we explore the 
use of SERS spectroscopy combined with multivariate 
analysis for non-invasive gastric cancer detection  
1  Materials and methods 
AgNO3 (mass fraction 99.8%, Reagent No. 1 Factory of 
Shanghai); NaOH (Sinopharm Chemical Reagent Co., Ltd.). 
All reagents used in experiments were of analytical grade. 
1.1  Preparation of silver colloids and human blood 
plasma samples 
Silver (Ag) colloids were prepared by the deoxidizing 
method in accordance with the report by Nicolae Leopold 
[31]. Briefly, a total of 4.5 mL of sodium hydroxide solu-
tion (0.1 mol L1) was added to 5 mL of 0.06 mol L1 hy-
droxylamine hydrochloride solution. The mixture was then 
added rapidly to 90 mL of 0.0011 mol L1 silver nitrate 
aqueous solution and the resulting mixture shaken until a 
homogeneous mixture was obtained. The resulting colloid 
had a milky gray color. The colloidal particles were charac-
terized by an absorption maximum at 418 nm with a full 
width at half-maximum of approximately 100 nm (Figure 1). 
The inserted picture in the figure shows a transmission elec-
tron microscopy (TEM) photograph of the prepared silver 
colloid. The particle sizes followed a normal distribution 
with a mean diameter of 34 nm and standard deviation of 5 
nm. The silver colloidal solution was concentrated by cen-
trifugation at 10000 r min1 for 10 min, discarding a portion 
of the supernatant and adjusting the final concentration for 
use later with the plasma samples. 
Two subject groups were studied in this work. The first 
group consisted of 32 patients with confirmed clinical and 
histopathological diagnosis of gastric cancers. The second 
group consisted of 33 healthy volunteers as a control group. 
After 12 h of overnight fasting, single 3 mL peripheral 
blood samples were obtained from the study subjects between 
7:00 and 8:00 a.m., using 10 µL of EDTA-K2 (15 g L1) as 
anticoagulant. Blood cells were removed by centrifugation at 
2000 r min1 for 15 min to obtain the blood plasma. Then, 
200 L blood plasma was mixed with 200 L silver colloi-
dal nanoparticles in a 1:1 proportion. This was mixed with 
a pipette tip to create as homogeneous a mixture as possible. 





Figure 1  The UV/visible absorption spectrum of silver colloid. The ab-
sorption maximum is located at 418 nm. The inserted picture shows a TEM  
micrograph of silver nanoparticles. 
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1.2  SERS measurements 
A drop of the above mixture was transferred onto a rectan-
gle aluminum plate (99.99%) and dried. The SERS spectra 
were recorded with a confocal Raman micro-spectrometer 
(Renishaw, Great Britain) in the range of 450–1800 cm1 
under a 785 nm and 5 mW diode laser excitation. The spec-
tra were collected in backscattering geometry using a mi-
croscope equipped with a Leica 20× objective with a 10 s 
integration time. Three spectra were obtained from a sample 
in different positions and the mean spectra from those were 
taken for analysis. 
2  Results and discussion 
The three spectra shown in Figure 2A–C were measured 
under the same instrumentation set-up. Figure 2A and B 
shows the SERS spectra of patient blood plasma with added 
Ag sol and the regular Raman spectrum of the blood plasma 
without Ag sol, respectively. A comparison of Figure 2A 
and B demonstrated that the intensity of many dominant 
vibrational bands has been increased dramatically by SERS, 
indicating that there were strong interactions between the 
silver colloids and the blood plasma. Because of this inter-
action, biochemical substances in plasma samples can 
closely adsorb on the silver colloid particle surfaces, thus 
leading to an extraordinary enhancement in the intensity of 
the Raman scattering. Only a few Raman peaks could be 
observed in the native blood plasma without the addition of 
silver solution because most of the Raman signals were 
masked by the large autofluorescence background. An obvi-
ous decrease in the intensity of the fluorescence background 
and clearly resolved, high intensity Raman bands were ob-
served in the SERS spectra. Figure 2C shows the back-
ground Raman signal of the anticoagulant with added Ag  
 
 
Figure 2  SERS spectrum of a blood plasma sample obtained by mixing 
the plasma with the Ag colloid at a 1:1 proportion (A), a regular Raman 
spectrum of the same plasma sample without the silver sol (B), and the 
background Raman signal of the anticoagulant agent mixed with the Ag  
colloid (C). 
sol. We see no interference signal in the spectral range of 
interest.  
To reduce the spectral intensity variations between dif-
ferent spectra and facilitate more accurate spectral shape 
analysis, all measured SERS spectra were normalized by the 
integrated area under the curve in the 450–1730 cm−1 
wavenumber range after the removal of fluorescence back-
ground from the original SERS data. Figure 3 compares the 
normalized mean SERS spectra obtained from 33 normal 
subject blood plasma samples (red line) and 32 gastric can-
cer patient plasma samples (black line). Shown at the top 
are the mean SERS spectra for healthy subject blood plasma 
and gastric cancer patient blood plasma with the standard 
deviations overlaid as shaded color fill. There are spectral 
regions where the standard deviations do not overlap and 
the differences are thus significant and reproducible. It can 
be seen that while significant SERS spectral differences 
exist between normal and tumor samples, primary SERS 
peaks at 494, 589, 638, 725, 813, 886, 1004, 1075, 1134, 
1207, 1330, 1445, 1580 and 1653 cm1 can all be observed 
in both normal and tumor blood plasmas, with the strongest 
signals at 494, 638 and 1134 cm−1. The normalized intensi-
ties of SERS peaks at 494, 589, 638, 813, and 1134 cm−1 are 
more intense for normal plasma than for tumor plasma, 
while SERS bands at 1330, 1445 and 1580 cm−1 are greater 
in gastric cancer plasma samples. These normalized inten-
sity differences can be viewed more clearly in the difference 
SERS spectrum between tumor and normal plasma samples 
(bottom in Figure 3). For example, the shoulder band varia-
tion at 1450 and 1580 cm−1 for gastric cancer plasma be-
comes more obvious on the difference spectrum. These 
spectral differences are explored in greater detail for blood 
plasma classification through principal component analysis 
in the next section. 
2.1  Analysis of the SERS spectra 
To test the capability of silver nanoparticles based plasma 
SERS spectra for differentiating gastric cancer from normal 
samples, principal component analysis (PCA) combined 
with linear discriminate analysis (LDA) was performed on 
the measured blood plasma SERS spectra. PCA is a statisti-
cal technique for simplifying complex data sets and deter-
mining the key variables in a multi- dimensional data set 
that best explain the differences in the observations. First, 
the fluorescence background of the original SERS data was 
removed using a fifth-order polynomial fitting algorithm [32], 
then each spectrum was normalized by the integrated area 
under the curve. The entire normalized SERS spectrum data 
set was fed into the SPSS software package (SPSS Inc., 
Chicago) for PCA–LDA analysis. Independent-sample T 
test on all the PC scores comparing normal and cancerous 
groups showed that there were three PCs (PC1, PC2 and 
PC7) that were most diagnostically significant (P<<0.05) 
for discriminating normal and cancerous groups. 
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Figure 4 shows the result of a three-dimensional scatter 
plot of PC scores (PC1, PC2 and PC7 as the three axes) for 
the healthy (black circles) and cancer (red triangles) groups. 
We can clearly see that they were distributed in separate 
areas except for a small overlap, which means that we are 
able to discriminate between the SERS spectra of the cancer 
group and the healthy control group. 
A similar three-dimensional scatter plot of PC scores 
(PC1, PC2 and PC4 as the three axes) as calculated from the 
original SERS data for the healthy (black circles) and can-
cer (red triangles) groups is also presented in Figure 5. In 
contrast to Figure 4, there is significant overlap between the 
cancer group and the healthy control group, indicating that 
the diagnosis effect will became poor without the SERS 
data pretreatment.  
 
 
Figure 3  Comparison of the mean spectrum for normal blood plasma 
(black line, n=33) versus that of gastric cancer (red line, n=32). The shaded 
areas represent the standard deviations of the means. Also shown at the  
bottom is the difference spectrum. 
 
Figure 4  A three-dimensional mapping of the PCA result for the gastric 
cancer group (red triangles) and the healthy volunteer group (black circles)  
with PC1, PC2 and PC7 as the three axes. 
To actually incorporate all significant spectral features, 
LDA was used to generate diagnostic algorithms using the 
PC score for the three most significant PCs (PC1, PC2 and 
PC7). To prevent over-training, the leave-one-out and cross- 
validation procedures were used. Figure 6 shows the poste-
rior probabilities of belonging to the normal (black circles) 
and cancer (red triangles) in the LDA model. Using a dis-
crimination threshold of 0.5, the diagnostic sensitivity and 
specificity for detecting gastric cancer were 79.5% and 91%, 
respectively. On the other hand, the PCA-LDA based diag-
nostic algorithms calculated from the original SERS data 
yielded a diagnostic sensitivity of 75% and specificity of 
66.7% for separating cancerous samples from normal sam-
ples. After the removal of the fluorescence background and  
 
 
Figure 5  A three-dimensional mapping of the PCA result as calculated 
from the original SERS data for the gastric cancer group (red triangles) and 
the healthy volunteer group (black circles) with PC1, PC2 and PC4 as the  
three axes. 
 
Figure 6  Scatter plots of the posterior probability of belonging to the 
normal (black circles) and gastric cancer (red triangles) categories using  
the PCA-LDA technique. The discrimination threshold was 0.5. 
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the normalization of the entire SERS spectrum data set, we 
found that the diagnostic specificity could be significantly 
increased. SERS data pretreatment can reduce adverse ef-
fects such as autofluorescence and experiment condition 
variations and facilitate more accurate spectral shape analy-
sis to achieve a better diagnosis performance. 
To further evaluate the performance of the PCA–LDA- 
based diagnostic algorithm for gastric cancer diagnosis, a 
receiver operating characteristic (ROC) curve was generated 
at different threshold levels (Figure 7). The data point la-
beled by the black arrow achieved a diagnostic sensitivity of 
79.5% and specificity of 91%, and the area under the ROC 
curve was 0.89. The result shows that the blood plasma 
SERS spectra can be used for gastric cancer detection with 
high sensitivity and specificity. 
2.2  Discussion 
The results of our exploratory study demonstrate that there 
were specific differences in SERS spectra for blood plasma 
of gastric cancer patient versus blood plasma of healthy 
subjects, suggesting great potential for SERS in gastric 
cancer detection and screening applications. SERS spectra 
of blood plasma are dominated by many vibrational modes 
of various biomolecules, such as proteins, lipids and nucleic 
acids, which may change in quantity or conformation asso-
ciated with neoplastic transformation. To better understand 
the molecular basis for the observed SERS spectra of human 
plasma, Table 1 lists tentative assignments for the observed 
SERS bands, according to data from the literature [33–39]. 
For example, the SERS peak at 1338 cm−1 due to the C–H 
vibration of nucleic acid bases exhibited a higher signal in 
cancer plasma, indicating an increase in the percentage of 
the nucleic acid bases content relative to the total SERS-     
active components in the plasma of gastric cancer patients. 
This is in agreement with studies of esophageal cancer, breast 
cancer, liver cancer, lung cancer and prostate cancer [40]. 
 
 
Figure 7  The receiver operating characteristic (ROC) curve of the dis-
crimination result for the PCA-LDA-based SERS spectral classification. 
Table 1  Peak positions and tentative assignments of major vibrational 
bands observed in plasma samplesa) 
Peak position 
(cm1) Vibrational mode Major assignments 
494 ring vibration cellulose, guanine, L-arginine 
589  ascorbic acid, amide-VI 
638 (C–S) L-tyrosine, lactose 
725 (C–H) adenine, coenzyme A 
813 (C–C–O) L-serine, glutathione 
886 (C–O–H) glutathione, D-(C)-galactosamine 
959 (C–C) -helix, proline, valine 
1004 vs (C–C) phenylalanine 
1074 (C–N) collagen 
1095 (C–N), D-mannos 
1134 (C–N), D-mannos, 
1207 ring vibration L-tryptophan, phenylalanine 
1330 (C–H) nucleic acid bases 
1445 (CH2) collagen, phospholipids 
1580 (C=C) phenylalanine, acetoacetate, ribo-flavin 
1654 (C=O) -helix, collagen 
a) , stretching vibration; δ, bending vibration; νs, symmetric stretch. 
 
Also, abnormal metabolism of DNA or RNA bases in the 
blood plasma of cancer patients may be detected in precan-
cerosis. The reason for increased cell-free nucleic acid lev-
els in cancer patients’ blood remains largely unknown. The 
main mechanisms are proposed to be apoptosis and necrosis, 
or release of intact cells in the bloodstream [41]. The results 
show that the occurrence and development of cancer may be 
monitored by detecting the metabolism of DNA or RNA 
bases in the blood plasma of cancer patients. 
The SERS band at 1445 cm1 corresponds to the CH 
bending mode of collagen or phospholipids, and is higher in 
cancer plasma than in normal plasma. The peak has previ-
ously been recognized as being of diagnostic significance 
[35]. The SERS band at 1580 cm−1 was attributed to the 
C=C bending mode of phenylalanine [37] and the percent-
age signals are considerably increased in cancer patient 
plasma, indicating an increase in the percentage of phenyl-
alanine content relative to the total SERS-active compo-
nents in the plasma of gastric cancer patients. Huang et al. 
also observed an increase of phenylalanine in malignant 
lung tissue by Raman spectroscopy [2]. The SERS bands of 
amide-VI (589 cm−1), L-tyrosine (638 cm−1), L-serine (813 
cm−1), D-(C)-galactosamine (886 cm−1) and D-mannos 
(1134 cm−1) in plasma of gastric cancer patients show lower 
percentage signals than those of normal plasma, suggesting 
a decrease in the percentage of amino acids and saccharide 
contents relative to the total SERS-active components in 
plasma of gastric cancer patients. The reason for this may 
be the tumor’s vigorous metabolism, which is consistent 
with other biochemical analysis results of tumor tissues. 
PCA was used to define a new dimensional space in 
which the major variance in the original data set can be 
captured and represented by only a few principal component 
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(PC) variables. These PCs are used to build a model with a 
resolution of recognition. Figure 4 shows the results of a 
three-dimensional scatter plot of PC scores (PC1, PC2 and 
PC7 as the three axes) for the healthy and cancer groups. 
We can clearly see that they were distributed in separate 
areas except for a small overlap. Figure 4 also shows that 
the regional distribution of the gastric cancer group is wider 
than that for the healthy control group. This is explainable. 
As the main medium for excretory product transportation, 
blood plasma delivers many dissolved nutrients, such as 
proteins, lipids, and sugars, to cells inside the entire body. 
Meanwhile, waste products are transported away from the 
same cells. Therefore, there are very complex components 
in blood plasma. For healthy people, the proportions of the-
se components are relatively stable. However, under patho-
logical conditions, cancer-related blood plasma constituents 
could be quite variable from patient to patient due to the 
heterogeneity of cancer development. These differences are 
probably responsible for the observed phenomenon that the 
regional distribution of the gastric cancer group on the PCA 
plot is much larger than for the healthy control group. 
3  Conclusion 
Silver nanoparticle-based, surface-enhanced Raman spec-
troscopy combined with multivariate analysis was applied 
to analyze the blood plasma from gastric cancer patients and 
healthy volunteers. Using a PCA-LDA diagnostic algorithm, 
we were able to differentiate gastric cancer from normal 
samples with high diagnostic sensitivity (79.5%) and speci-
ficity (91%). Tentative assignments of the Raman bands in 
the measured SERS spectra suggest interesting cancer-spe- 
cific biomolecular differences, including an increase in the 
relative amounts of nucleic acid, collagen, phospholipids 
and phenylalanine and a decrease in the percentage of ami-
no acids and saccharide contents in the blood plasma of 
cancer patients as compared with those of healthy subjects. 
These alterations may be due to the patients’ body metabol-
ic changes. The results from this exploratory study demon-
strate great promise for developing SERS plasma analysis 
combined with multivariate analysis into a clinical tool for 
non-invasive detection and screening of gastric cancers. 
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